Cochrane · systematic review · CD005266
Screening for type 2 diabetes mellitus
Peer, N, Balakrishna, Y, Durao, S · Cochrane Database of Systematic Reviews · 2020 · Cochrane Library
Metabolic and Endocrine DisordersAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
2
No studies
5
Included studies
NR
No studies 5 · 71.4%Ungraded 0 · 0%Very low 0 · 0%Low 2 · 28.6%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Screening for type 2 diabetes mellitus
Population: individuals without known diabetes mellitus but at high risk for the condition
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
All‐cause mortality Median | HR 1.06 [0.9, 1.25] | 1 study · 20184 participants | Low Downgraded: imprecision |
Diabetes‐related mortality Assessed according to whether diabetes was included anywhere on the death certificate | HR 1.26 [0.75, 2.12] | 1 study · 20184 participants | Low Downgraded: imprecision |
Diabetes‐related morbidity | no estimate extracted | NR | No studies |
Incidence of type 2 diabetes | no estimate extracted | NR | No studies |
Health‐related quality of life | no estimate extracted | NR | No studies |
Adverse events | no estimate extracted | NR | No studies |
Socioeconomic effects | no estimate extracted | NR | No studies |